Title

Draculin, the anticoagulant factor in vampire bat saliva, is a tight-binding, noncompetitive inhibitor of activated factor X. Biochim. Biophys.

Files

Link to Full Text

Download Full Text

Publisher

Elsevier

Publication Date

September 1999

Abstract

The kinetic mechanism of action of Draculin on activated Factor X (FXa) is established. Draculin inhibits activated Factor X within seconds of incubation at near equimolar concentration (2–6 times on molar basis). Fitting the data to the equation for a tight-binding inhibitor gives a value for Ki(Kd)=14.8±1.5 nM. The formation of the Draculin–FXa complex can be explained by a two-step mechanism, where for the first, reversible step, kon=1.117 (±0.169, S.E.M.)×106 M−1 s−1 and koff=15.388 (±1.672)×10−3 s−1, while for the second, irreversible step, which is concentration-independent, k2=0.072 s−1. Kd obtained from koff/kon=13.76 nM. Lineweaver–Burk plot shows a noncompetitive behavior. This noncompetitive mode of inhibition of Draculin is supported by the observation that Draculin, at concentrations giving complete inhibition, does not impair binding of p-aminobenzamidine to FXa. Moreover, under the same conditions, Draculin induces <14% decrease of the fluorescence intensity of the p-aminobenzamidine–FXa complex. We conclude that Draculin is a noncompetitive, tight-binding inhibitor of FXa, a characteristic so far unique amongst natural FXa inhibitors.

Notes

Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, Vol. 1434, no. 1 (1999-09-14).

Keywords

Fxa Inhibition, Draculin, Tight-Binding Inhibitor, Natural Anticoagulant, (Vampire Bat)

Description

RDA

Subject: topical

Fxa Inhibition; Draculin; Tight-Binding Inhibitor; Natural Anticoagulant; (Vampire Bat)

Type

Article

Genre

serial

Identifier

SFS0069815_00001

Share

COinS